Drug Shortage Report for OCTREOSCAN
Report ID | 174288 |
Drug Identification Number | 02329271 |
Brand name | OCTREOSCAN |
Common or Proper name | Octreoscan |
Company Name | CURIUM CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | PENTETREOTIDE INDIUM IN 111 CHLORIDE |
Strength(s) | 10MCG 111MBq |
Dosage form(s) | POWDER FOR SOLUTION KIT SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | Vial 10 mL |
ATC code | V09IB |
ATC description | |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2022-11-06 |
Actual start date | 2022-11-06 |
Estimated end date | 2022-11-10 |
Actual end date | 2022-11-10 |
Shortage status | Resolved |
Updated date | 2022-11-14 |
Company comments | Due to a delay in production of Indium-111 raw material, there will be a 24-hour delay in the release of Octreoscan. Product scheduled for shipment on Sunday, November 6 will not be available. Due to a low yield concentration with the Indium-111 raw material, we are unable to execute production on the lot of Octreoscan. As a result, product will not be available for shipment on Monday, November 7. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2572 BOUL. DANIEL-JOHNSON LAVAL, QUEBEC CANADA H7T 2R3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2022-11-14 | French | Compare |
v5 | 2022-11-14 | English | Compare |
v4 | 2022-11-14 | English | Compare |
v3 | 2022-11-14 | English | Compare |
v2 | 2022-11-10 | French | Compare |
v1 | 2022-11-10 | English | Compare |
Showing 1 to 6 of 6